期刊文献+

依福地平中间体的合成工艺改进

Improvement in the Synthesis of Efonidipine Intermediate
下载PDF
导出
摘要 以N-苄基苯胺为原料,经亲核取代、酯胺交换和氨基取代3步反应得到依福地平关键中间体3-氨基-2-丁烯酸-2-(N-苄基-N-苯基)氨基乙酯(氨基片段)。酯交换一步采用碱性催化剂替代原工艺中酸性催化剂;氨基取代一步添加ZSM-5分子筛催化,并采用不锈钢曝气头取代原工艺中导气管。新工艺缩短了反应的时间,降低了氨气的用量,提高了反应收率。改进后的工艺,总收率提高至72.4%,较原工艺提高了9.0%,生产成本降低,操作简便易行,适合工业化生产。 The key intermediate of [2-(N-benzyl-N-phenyl)amin]ethyl-3-amino-2-butenoat was obtained from N-benzeneimine via the nucleophilic substitution, transesterification and amino substitution. In the transesterification step, the alkaline catalyst was used to replace the acidic catalyst in the original process, the ZSM-5 molecular sieve catalysis and stainless steel aerator was added In the step of amino substitution. The new process shortens the reaction time, reduces the amount of ammonia, and improves the reaction yield. The total yield is increased to 72.4%, 9.0% higher than the original process. The production cost is reduced, the operation is simple and easy, and the method is suitable for industrial production.
出处 《精细化工中间体》 CAS 2016年第6期38-40,共3页 Fine Chemical Intermediates
基金 河南省科技厅产学研合作项目(152107000043) 河南省教育厅科学技术研究重点项目(14A530007)
关键词 依福地平 N-苄基苯胺 氨基取代 efonidipine N-benzeneimine amino substituted
  • 相关文献

参考文献3

二级参考文献22

  • 1李明,郭维斯,文丽荣,杨华铮.烯胺酮的合成及其在有机合成中的应用[J].有机化学,2006,26(9):1192-1207. 被引量:17
  • 2王宏社,苗建英.NaHSO_4·SiO_2催化合成β-烯胺酮(酯)[J].有机化学,2007,27(2):266-268. 被引量:12
  • 3RYOZO S, YOSHIMASA K, KIYOTOMO S. Synthesis of 1, 4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[ benzyl ( phenyl ) amino ] ethyl 5-(5, 5-dimethyl-2-oxo-1, 3, 2-dioxaphorinan-2- yl )-1, 4-dihydro-2, 6-dimethyl-4-( 3-nitrophyl )-3- pyridinecarboxylate hydrochloride ethanol ( NZ-105 ) and its crystal structure[J]. Chem Pharm Bull, 1992, 40(9) :2362 - 2369.
  • 4GAELLE L B, FREDERIC R, AGNES P, et al. Design and synthesis of imidaziline derivatives active on glucose homeostasis in a rat model of type Ⅱ diabetes. 2. Syntheses and biological activities of 1, 4-dialkyl, and 1-benzyl-4-alkyl-2-(4′, 5′-dihydro-1′ H-imidazol- 2′- yl) piperazines and isosteric analogues of imidazoline [J]. J Med Chem, 1999, 42(9) : 1587 - 1603.
  • 5RYOZO S, YOSHIMASA K, KIYOTOMO S. Synthesis and biological of optical isomers of 2-(4-diphenyl- methyl-l-piperazinyl) ethyl 5- ( 4, 6-dimethyl-2-oxo-1, 3, 2 - dioxaphosphorinan-2- yl )- 1,4-dihydro-2, 6-dimethyl-4 ( 3-nitrophenyl )-3-pyridine carboxylate dihydroehloride (NIP-101)[J]. Chem Pharm Bull, 1992, 40(9):2370 - 2376.
  • 6YOSHIMASA K, RYOZO S, KIYOTOMO S. Transformation of 1, 4-dihydropyridine ring of calcium antagonist NZ-105 into cyclohexenone [ J ]. Chem Pharm Bull, 1995, 43(2) :315 - 317.
  • 7IWAO M, MASAMI T, MASAHIRO K, et al, Reaction of cyclic phosphites with haloacetones [ J ]. Chem Pharm Bull, 1987, 35(12) :4711 - 4716.
  • 8RYOZO S, HIROO M, KIYOTOMO S. Novel synthesis of a-acetylstyryl phosphonates [ J ]. Synthesis, 1993 (7) :705 - 713.
  • 9Saulo J, Felizola A, Takashi M, et al. Voltage-gated calcium channels in the human adrenal and primary aldosteronism [J]. Steroid Bioehemistry and Molecular Biology, J Steroid BioChem, 2014, 144(10): 410-416.
  • 10Yuiehiro Y, Alexandros B, Georgel, et al. Effeets of antihypertensive treatment in Asian populations: A meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA)[J]. J Am Soc Hypertens, 2014, 8(2): 103-116.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部